Revelation Biosciences, Inc.
(NASDAQ:REVB)
$0.69
0.01 (0.88%)
At Close: 4:00 PM
$0.70
-0.04 (-5.00%)
Pre Market: 4:29 AM
REVB Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
REVB Stock Price Today
Revelation Biosciences, Inc. (REVB) stock rallied over 0.82% intraday to trade at $0.6856 a share on NASDAQ. The stock opened with a loss of 0.00% at $0.68 and touched an intraday high of $0.73, rising 0.82% against the last close of $0.68. The Revelation Biosciences, Inc. in stock market went to a low of $0.68 during the session.
REVB Stock Snapshot
$0.68
Prev. Close
4.32 Million
Market Cap
$0.68
Day Low
$0.68
Open
N/A
Number of Shares
$0.73
Day High
N/A
P/E ratio
-0.11
EPS (TTM)
2.49
Cash Flow per Share
N/A
Free Float in %
1.81
Book Value
33204.00
Volume
REVB Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
4660 La Jolla Village DriveSan Diego, CA 92122US
Website:https://www.revbiosciences.com
Contact #:650-800-3717
Company Information
EmployeesN/A
BetaN/A
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
Peers
Frequently Asked Questions
What is the current Revelation Biosciences, Inc. (REVB) stock price?
Revelation Biosciences, Inc. (NASDAQ: REVB) stock price is $0.69 in the last trading session. During the trading session, REVB stock reached the peak price of $0.73 while $0.68 was the lowest point it dropped to. The percentage change in REVB stock occurred in the recent session was 0.82% while the dollar amount for the price change in REVB stock was $0.01.
REVB's industry and sector of operation?
The NASDAQ listed REVB is part of Biotechnology industry that operates in the broader Healthcare sector. Revelation Biosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics.
Who are the executives of REVB?
Mr. Chester Stanley Zygmont III
Chief Financial Officer & Corporation Sec.
Ms. Carol Odle
Senior Director of Clinical Projects
Mr. James M. Rolke
Chief Executive Officer & Director
Mr. Chester Stanley Zygmont III
Chief Financial Officer
How REVB did perform over past 52-week?
REVB's closing price is 0.17% higher than its 52-week low of $0.64 where as its distance from 52-week high of $17.535 is -0.98%.
How many employees does REVB have?
Number of REVB employees currently stands at N/A. REVB operates from 4660 La Jolla Village Drive, San Diego, CA 92122, US.
Link for REVB official website?
Official Website of REVB is: https://www.revbiosciences.com
How do I contact REVB?
REVB could be contacted at phone #650-800-3717 and can also be accessed through its website. REVB operates from 4660 La Jolla Village Drive, San Diego, CA 92122, US.
How many shares of REVB are traded daily?
REVB stock volume for the day was 33204.00 shares. The average number of REVB shares traded daily for last 3 months was 95.68 Thousands.
What is the market cap of REVB currently?
The market value of REVB currently stands at $4.32 Million with its latest stock price at $0.69 and N/A of its shares outstanding.